Answers are grounded in this paper and cite their sources.
Reduced signaling via the NO-cGMP pathway is a mediator of vascular inflammation and insulin resistance during overnutrition induced by high-fat feeding. Therefore, phosphodiesterase-5, soluble guanylyl cyclase, and other molecules in the NO-cGMP pathway (eg, protein kinase G) constitute potential targets for the treatment of vascular dysfunction in the setting of obesity.
No takes yet. Share an insight, caveat, or question.
Rizzo et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: